Clinical Trial Update: Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab in bladder cancer patients undergoing radical cystectomy has completed and posted results as of 2024-06-25.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stage I Bladder Cancer AJCC v8, Stage II Bladder Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2024-06-25